Evidence map›Paper›PMID 15834752›Full record

ArticleMedical microbiology and immunology2005

Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin.

Xiaogang Hou, Edgar Suquilanda, Ana Zeledon, Apollo Kacsinta, Akila Moore, Joseph Seto, Nancy McQueen

Open access · bronzeAbstract read
In one paragraph

Article in Medical microbiology and immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaogang HouDepartment of Biological Sciences, California State University, Los Angeles, 5151 State University Drive, Los Angeles, CA 90032, USA.
Edgar Suquilanda
Ana Zeledon
Apollo Kacsinta
Akila Moore
Joseph Seto
Nancy McQueen
California State University Los Angeles · US

Funding

Research Initiative for Scientific Enhancement (RISE)R25GM061331 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI FOSTER, KRISHNA L · 2000 to 2021
$33.1M
Voltammetric, Surface, and Kinetic Studies of p53 and Amyloidogenic ProteinsS06GM008101 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI GUTIERREZ, CARLOS GABRIEL · 1989 to 2008
$20.8M
UNDERGRADUATE STUDENT TRAINING IN ACADEMIC RESEARCHT34GM008228 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI TUNSTAD, LINDA M. · 1986 to 2022
$13.3M
TWO-YEAR TO FOUR-YEAR TRANSITION PROGRAMR25GM049001 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI DINH, KIM-LIEN THI, MATHIAS, ERROL V · 1992 to 2022
$5.3M
LOS ANGELES BASIN BRIDGES TO THE PHD PROGRAMR25GM054939 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI DRAKE REITAN, MEREDITH, GUTIERREZ, CARLOS GABRIEL · 1996 to 2020
$3.4M
NIGMS NIH HHS GM 08228NIGMS NIH HHS GM 49001NIGMS NIH HHS GM 54939NIGMS NIH HHS GM 61331NIGMS NIH HHS R25 GM049001NIGMS NIH HHS R25 GM054939NIGMS NIH HHS R25 GM061331NIGMS NIH HHS S06 GM008101NIGMS NIH HHS SO6 GM 8101-30NIGMS NIH HHS T34 GM008228
6 · The paper itself

Abstract

With the emergence of new viruses, such as the SARS virus and the avian influenza virus, the importance of investigations on the genetic basis of viral infections becomes clear. Sendai virus causes a localized respiratory tract infection in rodents, while a mutant, F1-R, causes a systemic infection. It has been suggested that two determinants are responsible for the systemic infection caused by F1-R [Okada et al (1998) Arch Virol 143:2343-2352]. The primary determinant of the pantropism is the enhanced proteolytic cleavability of the fusion (F) protein of F1-R, which allows the virus to undergo multiple rounds of replication in many different organs, whereas wild-type virus can only undergo multiple rounds of replication in the lungs. The enhanced cleavability of F1-R F was previously attributed to an amino acid change at F115 that is adjacent to the cleavage site at amino acid 116. Secondly, wild-type virus buds only from the apical domain of bronchial epithelium, releasing virus into the lumen of the respiratory tract, whereas F1-R buds from both apical and basolateral domains. Thus, virus is released into the basement membrane where it can easily gain access to the bloodstream for dissemination. The microtubule disruption is attributed to two amino acid differences in M protein. To confirm that the F and M gene mutations described above are solely responsible for the phenotypic differences seen in wild-type versus F1-R infections, reverse genetics was used to construct recombinant Sendai viruses with various combinations of the mutations found in the M and F genes of F1-R. Plaque assays were performed with or without trypsin addition. A recombinant virus containing all F1-R M and F mutations formed plaques in LLC-MK2 cells and underwent multiple cycles of replication without trypsin addition. To clarify which mutation(s) are necessary for plaque formation, plaque assays were done using other recombinant viruses. A virus with only the F115 change, which was previously thought to be the only change important for plaque formation of F 1-R F, did not confer upon the virus the ability to form plaques without the addition of trypsin. Another virus with the F115 and both M changes gave the same result. Therefore, more than one mutation in the F gene contributes to the ability of F1-R to form plaques without trypsin addition.

Indexed as

MutationViral Plaque AssayRecombination, GeneticSendai virusTrypsinViral Fusion ProteinsViral Matrix ProteinsVirus ReplicationM protein, Sendai virusTrypsinViral Fusion ProteinsViral Matrix Proteins

Identifiers

PMID15834752
PMCPMC7086596
OpenAlexW2068544855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.